Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board
09 October 2019
We propose the establishment of a new Developing Antibiotics for Resistant Targets (DART) Board to improve the targeting of incentives for antibiotic development. The DART Board would comprise clinical experts, patient advocates, and representatives from government, industry, and nonprofit organizations.
Further reading: Annals of Internal Medicine
Author(s): Brad Spellberg, MD; Travis B. Nielsen, PhD; David N. Gilbert, MD; Andrew F. Shorr, MD, MPH, MBA; Eric P. Brass, MD, PhD
Smart Innovations
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.